Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar;67(3):729-732.
doi: 10.1007/s12020-019-02132-3. Epub 2019 Nov 16.

HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease

Affiliations
Free article
Case Reports

HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease

Valeria Cambria et al. Endocrine. 2020 Mar.
Free article

Abstract

Context: Hirata's disease (HD) is a rare autoimmune cause of hypoglycemia. Patients suffering from this condition have a genetic predisposition, determined by HLA DR4, with some differences in the worldwide population. In Caucasians HLA DRB1*0403 is the most frequent susceptibility background on which some drugs play as triggers.

Case description: We reported the case of a woman with several hypoglycemic episodes, characterized by high insulin and c-peptide levels. Biochemical and morphological exams excluded a neuroendocrine tumor. HD was diagnosed according to insulin autoantibodies positivity and patient's history, particularly about drugs taken. The HLA analysis revealed DRB1*0415 allele.

Conclusions: We found a potential new predisposing factor for HD, HLA DRB1*0415 allele, never described before as genetic background to insulin autoimmune syndrome in Caucasians.

Keywords: Alpha-lipoic acid; Hypoglycemia; Insulin autoantibodies; Insulin autoimmune syndrome.

PubMed Disclaimer

References

    1. S. Takayama-Hasumi, Y. Eguchi, A. Sato, C. Morita, Y. Hirata, Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan. Diabetes Res. Clin. Pract. 10, 211–214 (1990) - DOI
    1. Y. Uchigata, Y. Hirata, Y. Iwamoto, Drug-induced insulin autoimmune syndrome. Diabetes Res. Clin. Pract. 83, e19–e20 (2009) - DOI
    1. S. Censi, C. Mian, C. Betterle, Insulin autoimmune syndrome: from diagnosis to clinical management. Ann. Transl. Med. 6(17), 335–350 (2018) - DOI
    1. Y. Uchigata, Y. Hirata, Y. Omori, Y. Iwamoto, K. Tokunaga, Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum. Immunol. 61, 154–157 (2000) - DOI
    1. P.E. Cryer, L. Axelrod, A.B. Grossman et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 94, 709–728 (2009) - DOI

Publication types